Clinical Trial Update: Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU

View source ↗

Summary

This completed preliminary clinical trial evaluated how Palynziq-related changes in phenylalanine impact brain function in individuals with phenylketonuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Phenylketonurias | Status: COMPLETED